CN1778903A - A high-density continuous perfusion culture method for animal cells - Google Patents
A high-density continuous perfusion culture method for animal cells Download PDFInfo
- Publication number
- CN1778903A CN1778903A CNA2005100301993A CN200510030199A CN1778903A CN 1778903 A CN1778903 A CN 1778903A CN A2005100301993 A CNA2005100301993 A CN A2005100301993A CN 200510030199 A CN200510030199 A CN 200510030199A CN 1778903 A CN1778903 A CN 1778903A
- Authority
- CN
- China
- Prior art keywords
- acid
- cell
- cells
- culture
- rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及动物细胞大规模、高密度、无血清连续灌注培养方法。The invention relates to a large-scale, high-density, serum-free continuous perfusion culture method for animal cells.
技术背景technical background
生物反应器中动物细胞的培养过程可以有不同的操作方式,如分批培养(Batch)、连续培养(Continuous)、灌注培养(Perfusion)以及流加培养(Fed-batch)等,不同的操作方式有其不同的特点。The cultivation process of animal cells in the bioreactor can have different operation modes, such as batch culture (Batch), continuous culture (Continuous), perfusion culture (Perfusion) and fed-batch culture (Fed-batch), etc., different operation modes has its different characteristics.
连续灌注培养,就是在培养过程中以一定速率加入新鲜营养液,并以相同速率排出上清液,同时通过反应器上附加的细胞截留系统将大多数活细胞与上清液及死细胞、细胞碎片等分离,活细胞返回至反应器内继续培养。连续灌注培养不仅保持了较恒定的培养状态,避免了有害代谢副产物的积累,而且使反应器内的细胞达到比较高的密度。Continuous perfusion culture is to add fresh nutrient solution at a certain rate during the culture process, and discharge the supernatant at the same rate. The fragments are separated, and the living cells are returned to the reactor to continue culturing. Continuous perfusion culture not only maintains a relatively constant culture state, avoids the accumulation of harmful metabolic by-products, but also enables the cells in the reactor to reach a relatively high density.
近年来动物细胞培养在细胞生理学研究,特别是在认识影响细胞生长与活力的不利因素方面已经取得了很大的进步。通过分子遗传控制,细胞更易于在不含动物蛋白的培养基中培养。在工程研究中,得到高细胞密度和高细胞活性逐渐成为普遍的话题。关于补料培养和灌注培养中补料的控制方案,越来越多的努力投向过程控制和监测,这对于保证产品质量和过程的连贯性是有益的。大规模动物细胞培养中由于大量细胞的代谢,培养过程中细胞培养环境迅速改变,在线过程监控十分重要。在线测定反应器中培养条件、代谢产物和目的产物等大量数据,并对测定结果进行分析处理,及时对培养系统进行反馈控制,才能成功地进行大规模动物细胞培养。In recent years, animal cell culture has made great progress in the study of cell physiology, especially in the understanding of unfavorable factors that affect cell growth and vitality. Through molecular genetic control, cells are more easily cultured in animal protein-free media. Obtaining high cell density and high cell viability has gradually become a common topic in engineering research. With regard to control schemes for feeding in fed and perfusion cultures, more and more efforts are being devoted to process control and monitoring, which is beneficial to ensure product quality and process consistency. Due to the metabolism of a large number of cells in large-scale animal cell culture, the cell culture environment changes rapidly during the culture process, and online process monitoring is very important. Large-scale animal cell culture can be successfully carried out by online measurement of a large amount of data such as culture conditions, metabolites and target products in the reactor, analysis and processing of the measurement results, and timely feedback control of the culture system.
对于任何给定的动物细胞,目标产物浓度与细胞密度和培养时间的积分成正比,即P=q∫Xvdt,因此要提高产物浓度及其产率有两个途径,首先是提高活细胞的密度,其次是维持尽可能长的培养时间,而这与培养基组成和细胞培养环境密切相关。众所周知,动物细胞维持生长、成活并进行产物合成需要三十多种营养成分,包括葡萄糖、必需氨基酸、维生素、某些血清成分和无机盐等,其中葡萄糖和谷氨酰胺是细胞生长、代谢和产物合成中最主要的碳源和能源物质,同时动物细胞还需要适宜的培养环境,包括pH、渗透压、溶解氧和温度等。在细胞培养过程中只要有一种营养物被耗竭,就会限制细胞生长、代谢和产物合成,因此细胞培养过程中各种营养物的供给往往决定了生物反应器的产率。然而,动物细胞生长除了要消耗营养物之外,还会生成许多代谢副产物,如氨、乳酸、非必需氨基酸和CO2等。这些副产物积累到一定程度往往会对细胞产生毒性作用或改变培养环境的pH和渗透压,从而抑制细胞生长和产物合成。现有大量研究证明动物细胞培养过程中营养物耗竭和代谢副产物积累的矛盾是限制细胞密度、产物浓度和培养过程产率的主要因素。为了消除营养限制,有人曾试图在渗透压许可范围内对培养基进行浓缩或添加营养成分,然而最终的结果是虽然营养物仍大量富余,但收效却甚微,究其原因是培养基中的高浓度葡萄糖和谷氨酰胺等营养物质促使了乳酸、氨和丙氨酸等代谢副产物的大量积累所致。为了减少乳酸和氨的生成与积累,近几年有研究者也作了多种尝试。例如有学者用果糖、麦芽糖和半乳糖作为碳源代替葡萄糖,虽然乳酸生成显著减少,但细胞的能量代谢更多的转向谷氨酰胺,从而生成更多的氨。另一方面,有研究者使用通过水解能生成谷氨酰胺的二肽(丙氨酰—谷氨酰胺和甘氨酰—谷氨酰胺)来代替培养基中游离的谷氨酰胺,虽然在培养基高温消毒和长期保存方面有一定优势,但未能达到预期的降氨效果,相反导致了大量的丙氨酸和甘氨酸积累,使培养基渗透压显著升高至对细胞生长有害的水平。其它在降氨方面的尝试还包括:通过诱导使细胞完全不需要谷氨酰胺,克隆谷氨酰胺合成酶至细胞中,以及使用渗透膜和电解等手段选择性去除氨或铵离子等,但所有这些努力至今仍未获任何理想结果。For any given animal cell, the target product concentration is directly proportional to the integral of cell density and culture time, that is, P=q∫X v dt, so there are two ways to increase the product concentration and its yield, the first is to increase the concentration of living cells The density, followed by maintaining the culture time as long as possible, which is closely related to the composition of the medium and the cell culture environment. As we all know, animal cells need more than 30 kinds of nutrients to maintain growth, survival and product synthesis, including glucose, essential amino acids, vitamins, some serum components and inorganic salts, etc. Among them, glucose and glutamine are the main components of cell growth, metabolism and product synthesis. It is the most important carbon source and energy substance in the synthesis. At the same time, animal cells also need a suitable culture environment, including pH, osmotic pressure, dissolved oxygen and temperature. As long as one nutrient is depleted during the cell culture process, cell growth, metabolism and product synthesis will be limited, so the supply of various nutrients during the cell culture process often determines the yield of the bioreactor. However, in addition to consuming nutrients, animal cell growth also generates many metabolic by-products, such as ammonia, lactic acid, non-essential amino acids, and CO2 . Accumulation of these by-products to a certain extent often produces toxic effects on cells or changes the pH and osmotic pressure of the culture environment, thereby inhibiting cell growth and product synthesis. A large number of existing studies have proved that the contradiction between nutrient depletion and metabolic by-product accumulation during animal cell culture is the main factor limiting cell density, product concentration and yield of the culture process. In order to eliminate the nutrient limitation, some people have tried to concentrate or add nutrients to the medium within the permitted range of osmotic pressure. However, the final result is that although the nutrients are still abundant, the effect is minimal. The reason is that the medium in the medium High concentrations of nutrients such as glucose and glutamine promote the accumulation of metabolic by-products such as lactic acid, ammonia and alanine. In order to reduce the formation and accumulation of lactic acid and ammonia, researchers have also made various attempts in recent years. For example, some scholars use fructose, maltose and galactose as carbon sources instead of glucose. Although the production of lactic acid is significantly reduced, the energy metabolism of cells is more shifted to glutamine, thereby generating more ammonia. On the other hand, some researchers used dipeptides (alanyl-glutamine and glycyl-glutamine) that can generate glutamine by hydrolysis to replace free glutamine in the medium, although in the medium High-temperature disinfection and long-term storage have certain advantages, but failed to achieve the expected effect of reducing ammonia. On the contrary, it led to the accumulation of a large amount of alanine and glycine, which significantly increased the osmotic pressure of the medium to a level that was harmful to cell growth. Other attempts to reduce ammonia include: making cells completely do not need glutamine by inducing cells, cloning glutamine synthetase into cells, and using permeable membranes and electrolysis to selectively remove ammonia or ammonium ions, etc., but all These efforts have so far not yielded any desired results.
事实上,动物细胞在培养过程中对营养物质的代谢途径受到培养环境和营养物浓度的严格调控,营养物代谢途径不同,能量利用率和副产物生成具有显著差异,最典型的是细胞对葡萄糖和谷氨酰胺的代谢。在一般批式培养过程中,由于葡萄糖浓度比较高,促使大部分(大于70%)葡萄糖通过糖酵解途径代谢,导致乳酸的大量积累,且只能生成2mmolATP/mmol葡萄糖;谷氨酰胺代谢也是如此,高浓度的谷氨酰胺将加速脱氨降解使谷氨酸和氨大量积累,同时高浓度的谷氨酸又通过谷氨酸—丙酮酸转氨酶途径生成α-酮戊二酸进入三羧酸循环,导致丙氨酸大量积累,使培养基渗透压升高,且只生成9mmolATP/mmol谷氨酰胺。细胞代谢过程生化反应动力学研究表明,细胞对葡萄糖的消耗主要受易化扩散控制,细胞膜上的葡萄糖浓度梯度是其唯一的推动力。当葡萄糖浓度较低时,细胞也可通过由Na+离子梯度推动的高亲和性(米氏常数Km低于0.2mM)同向转运过程摄取葡萄糖。另外,转化细胞的线粒体己糖激酶活性高,且不受葡萄糖-6-P的反馈调节,因此高浓度的葡萄糖-6-P往往会强化糖酵解途径。同样,培养基中高浓度谷氨酰胺也导致细胞对谷氨酰胺的高速摄取,谷氨酰胺脱氨降解的第一步与谷氨酰胺酶同功酶的米氏常数Km相对较高(2.2至4.5mM)有关,且这一步在热力学上是相当有利的(平衡常数K=320),但它同时对降低胞内谷氨酰胺浓度非常敏感。糖酵解和谷氨酰胺脱氨降解途径的终点都在丙酮酸,致使它在线粒体两侧积聚。当过量的丙酮酸积累超过了线粒体的氧化能力时,将迫使细胞以乳酸和丙氨酸形式分泌过剩的碳源。动物细胞的上述代谢特点就是导致为什么在批式培养中不可能解决营养物耗竭和副产物积累这一矛盾的根本原因。In fact, the metabolic pathways of animal cells to nutrients are strictly regulated by the culture environment and nutrient concentration during the culture process. Different nutrient metabolic pathways have significant differences in energy utilization and by-product generation. and glutamine metabolism. In the general batch culture process, due to the relatively high glucose concentration, most (more than 70%) glucose is metabolized through the glycolysis pathway, resulting in a large accumulation of lactic acid, and only 2mmolATP/mmol glucose can be generated; glutamine metabolism is also In this way, the high concentration of glutamine will accelerate the deamination degradation, so that glutamic acid and ammonia will accumulate in large quantities, and at the same time, the high concentration of glutamic acid will generate α-ketoglutarate into tricarboxylic acid through the glutamic acid-pyruvate transaminase pathway. Cycle, resulting in a large accumulation of alanine, the medium osmotic pressure increased, and only produce 9mmolATP/mmol glutamine. Studies on the kinetics of biochemical reactions in the process of cell metabolism have shown that the consumption of glucose by cells is mainly controlled by facilitated diffusion, and the concentration gradient of glucose on the cell membrane is its only driving force. When the glucose concentration is low, cells can also take up glucose through a high-affinity (Menten constant K m lower than 0.2 mM) symport process driven by the Na + ion gradient. In addition, the mitochondrial hexokinase activity of transformed cells is high and not subject to feedback regulation by glucose-6-P, so high concentrations of glucose-6-P tend to enhance the glycolytic pathway. Similarly, the high concentration of glutamine in the medium also leads to the high-speed uptake of glutamine by cells, and the first step of glutamine deamination degradation is relatively high with the Michaelis constant K m of glutaminase isoenzyme (2.2 to 4.5 mM), and this step is quite favorable thermodynamically (equilibrium constant K=320), but it is also very sensitive to reducing intracellular glutamine concentration. Both the glycolytic and glutamine deamination degradation pathways terminate in pyruvate, leading to its accumulation on both sides of the mitochondria. When excess pyruvate accumulation exceeds the oxidative capacity of mitochondria, the cells are forced to secrete excess carbon sources in the form of lactate and alanine. The above-mentioned metabolic characteristics of animal cells are the fundamental reasons why it is impossible to resolve the contradiction between nutrient depletion and by-product accumulation in batch culture.
采用葡萄糖和谷氨酰胺限制的流加培养或灌注培养,可望消除批式培养中一开始浓度过高而后耗竭的缺陷,通过加料使培养基中的葡萄糖和谷氨酰胺浓度控制在比较低的水平并得到不断补充,代谢副产物不断被稀释或排除,近几年国外许多研究者的实验结果预示这种培养方式可为调控细胞进入高能代谢途径并减少副产物积累提供帮助。例如,Glacken等人(1998,Biotechnol. Bioeng.32:491-506)通过流加谷氨酰胺使其浓度在MDCK细胞的微载体培养中维持低水平,结果氨的生成减少了60%,同样,Ljunggren和Haggestrom(1992,Cytotechnology 8:45-56)在骨髓瘤细胞培养中采用谷氨酰胺限制的流加培养,使氨生成降低了50%。进而,他们研究了在杂交瘤细胞培养中同时限制葡萄糖和谷氨酰胺的流加培养,结果发现乳酸、氨和丙氨酸生成显著减少,而能量利用率、细胞密度和产物浓度得到显著提高(1994,Biotechnol. Bioeng.44:808-818)。然而,这些学者的研究工作尚存在一些不足,主要是他们往往只考虑了葡萄糖和/或谷氨酰胺,流加的培养基是非平衡培养基,限制补料一段时间后其它营养物质成为细胞生长的限制性因素,最后往往是造成细胞大量死亡,死细胞数大于活细胞数,而活细胞密度和产物浓度的提高仍然有限。虽然培养基连续灌注培养比流加培养更有优势,除了能不断补充营养物之外还能及时排去代谢副产物,因此所获得的细胞密度可比批式培养提高一至二个数量级,但是目前所研究和应用的灌注培养,由于其培养基是非平衡的,因此往往以高速率培养基灌注为代价,且使产物浓度大量稀释,在经济上得不偿失。The fed-batch culture or perfusion culture limited by glucose and glutamine is expected to eliminate the defect that the initial concentration is too high and then depleted in batch culture, and the concentration of glucose and glutamine in the medium can be controlled at a relatively low level by feeding. In recent years, the experimental results of many foreign researchers indicate that this culture method can help regulate cells entering high-energy metabolic pathways and reduce the accumulation of byproducts. For example, people such as Glacken (1998, Biotechnol. Bioeng. 32:491-506) make its concentration maintain low level in the microcarrier culture of MDCK cell by feeding glutamine, the generation of result ammonia reduces 60%, same, Ljunggren and Haggestrom (1992, Cytotechnology 8:45-56) used glutamine-limited fed-batch culture in myeloma cell culture, which reduced ammonia production by 50%. Furthermore, they studied the simultaneous limitation of glucose and glutamine fed-batch culture in hybridoma cell culture, and found that the production of lactic acid, ammonia and alanine was significantly reduced, while the energy utilization rate, cell density and product concentration were significantly improved ( 1994, Biotechnol. Bioeng. 44:808-818). However, there are still some deficiencies in the research work of these scholars. The main reason is that they often only consider glucose and/or glutamine. The limiting factor, in the end, often causes a large number of cells to die, the number of dead cells is greater than the number of living cells, and the increase of living cell density and product concentration is still limited. Although the medium continuous perfusion culture has more advantages than fed-batch culture, in addition to continuously supplementing nutrients, it can also remove metabolic byproducts in time, so the obtained cell density can be increased by one to two orders of magnitude compared with batch culture, but the current The perfusion culture in research and application, because its culture medium is non-balanced, often at the expense of high-speed culture medium perfusion, and the product concentration is greatly diluted, which is not worth the candle economically.
发明内容Contents of the invention
本发明需要解决的技术问题是公开一种动物细胞高密度连续灌注培养方法,以克服现有技术存在的缺陷,满足有关方面的需要。The technical problem to be solved in the present invention is to disclose a high-density continuous perfusion culture method for animal cells, so as to overcome the defects in the prior art and meet the needs of related parties.
本发明的方法包括如下步骤:Method of the present invention comprises the steps:
(1)目标细胞株在初始培养基中进行批培养;(1) Batch culture of the target cell line in the initial culture medium;
(2)计算培养过程中的细胞生长、培养基中各种营养物消耗和代谢副产物生成以及目标产物生成等动力学参数;(2) Calculating kinetic parameters such as cell growth, consumption of various nutrients in the medium, generation of metabolic by-products, and generation of target products during the culture process;
(3)根据计算结果重新设计灌注培养过程中的初始培养基和灌注培养基的营养物组成,并进行灌注培养;(3) Redesign the initial medium and the nutrient composition of the perfusion medium in the perfusion culture process according to the calculation results, and carry out perfusion culture;
重复(3)~(4)步骤对计算结果进行迭代优化,并根据培养过程所需达到的细胞密度和生产能力设定培养基连续灌注的速率,以获得高的细胞密度和目标产物浓度。动力学方程及计算批培养参数计算动力学方程细胞:
灌注培养参数计算动力学方程Calculation of Kinetic Equations for Perfusion Culture Parameters
物料进出速率相等,大部分细胞截留在反应器中,总稀释率D=F/V,上清流出率Ds=Fs/V,细胞流出率Db=Fb/V。The inflow and outflow rates of materials are equal, most of the cells are trapped in the reactor, the total dilution rate D = F/V, the supernatant outflow rate D s = F s /V, and the cell outflow rate D b = F b /V.
细胞:
营养物:
产物:
在稳定状态下,μ=kd+Db,
符号说明:Symbol Description:
Xv 活细胞密度(106cells/mL)Xv viable cell density (10 6 cells/mL)
Xt 总细胞密度(106cells/mL)Xt total cell density (10 6 cells/mL)
Viability 细胞活性(%)Viability Cell Viability (%)
μ 细胞比生长速率(day-1)μ Cell specific growth rate (day -1 )
D 灌注速率或称稀释率(day-1)D perfusion rate or dilution rate (day -1 )
F 流加速率(mL/day)F Flow rate (mL/day)
Gluc,Gln 底物浓度(mM)Gluc, Gln Substrate Concentration (mM)
Lac,Amm 副产物浓度(mM)Lac, Amm By-product concentration (mM)
MAb 单抗浓度(mg/L)MAb Monoclonal antibody concentration (mg/L)
qGluc qGln或qs 底物比消耗速率(mmol/109cells/day)Specific consumption rate of q Gluc q Gln or q s substrate (mmol/10 9 cells/day)
pLac pAmm pAla 副产物比生成速率(mmol/109cells/day)p Lac p Amm p Ala by-product specific formation rate (mmol/10 9 cells/day)
pMAb 单抗比生产速率(mg/109cells/day)Specific production rate of p MAb monoclonal antibody (mg/10 9 cells/day)
Yx/GlueYx/Gln 单位底物消耗的细胞产率(109cells/mmol)Cell yield of Y x/Glue Y x/Gln unit substrate consumption (10 9 cells/mmol)
Ylac/GlucYAmm/Gln 单位营养物消耗的副产物产率(mmol/mmol)By-product yield of Y lac/Gluc Y Amm/Gln unit nutrient consumption (mmol/mmol)
V 培养体积(mL)V Culture volume (mL)
更具体的包括如下步骤:More specifically, the following steps are included:
(1)将需要培养的细胞在无血清培养基中采用常规的方法进行传代适应后,接种于生物反应器中,接种密度为1.5~3.0×105细胞/ml;(1) After the cells to be cultured are subcultured in a serum-free medium by a conventional method, they are inoculated in a bioreactor with an inoculation density of 1.5-3.0×10 5 cells/ml;
(2)反应器设置为温度37℃,pH为7.2,溶氧50%,搅拌转速40~80转/分钟。在无血清初始培养基中,培养50~60小时后,将无血清灌注培养基以灌注速率D=1.0v/vday-1的速度进入生物反应器进行灌注培养,培养周期为30~60天,从第10天起开始收液,细胞密度可达1.0~2.40×107cells/ml,产物浓度可达批培养的10倍以上;(2) The reactor is set at a temperature of 37°C, a pH of 7.2, a dissolved oxygen of 50%, and a stirring speed of 40-80 rpm. In the serum-free initial medium, after culturing for 50-60 hours, the serum-free perfusion medium enters the bioreactor at a rate of perfusion rate D=1.0v/vday -1 for perfusion culture, and the culture period is 30-60 days. Collect liquid from the 10th day, the cell density can reach 1.0~2.40×10 7 cells/ml, and the product concentration can reach more than 10 times of batch culture;
所说的细胞包括杂交瘤细胞、重组CHO细胞、293细胞、昆虫细胞、NSO等工程细胞Said cells include hybridoma cells, recombinant CHO cells, 293 cells, insect cells, NSO and other engineered cells
无血清初始培养基的组分和含量如下:
无血清灌注培养基的组分和含量如下:
本发明的方法具有以下特点:Method of the present invention has following characteristics:
1.本发明中所用的培养基是无血清培养基;1. The medium used in the present invention is a serum-free medium;
2.在无血清培养基中添加了葡萄糖、谷氨酰胺、必需氨基酸以及细胞生长所需的其它营养物质;2. Glucose, glutamine, essential amino acids and other nutrients required for cell growth were added to the serum-free medium;
3.无血清培养基中所添加的物质是根据培养过程中细胞生长和代谢的特性,对动力学参数进行分析、计算和优化后,形成营养平衡的无血清培养基,既避免了营养物不足造成限制,也避免了营养物过剩造成代谢副产物的大量积累;3. The substances added in the serum-free medium are based on the characteristics of cell growth and metabolism during the culture process. After analyzing, calculating and optimizing the kinetic parameters, a nutritionally balanced serum-free medium is formed, which avoids nutrient deficiency. Create restrictions and avoid excessive accumulation of metabolic by-products caused by excess nutrients;
4.利用本发明优化的培养基和优化的灌注策略,可以在较低的灌注速率下获得较高的细胞密度,从而使产物浓度得到显著提高,避免了高灌注速率下目标产物的稀释。4. Using the optimized medium and optimized perfusion strategy of the present invention, higher cell density can be obtained at a lower perfusion rate, thereby significantly increasing the product concentration and avoiding the dilution of the target product at a high perfusion rate.
动物细胞培养的无血清培养基除无机盐外还有葡萄糖、谷氨酰胺、各种氨基酸、各种生长因子、调节和运输蛋白等30多种营养成分组成,任何一种营养物的缺乏都会造成细胞生长受到限制甚至导致细胞死亡;而营养物过度丰富则会使代谢副产物如氨和乳酸的大量积累,同样可导致细胞停止生长或死亡。研究表明,要有效地降低氨和乳酸的产量,必需降低葡萄糖和谷氨酰胺的浓度。本发明通过研究细胞生长、营养物消耗和代谢副产物积累的动力学特性,来研究细胞生长和营养物消耗和代谢副产物积累之间的代谢规律,确定和控制细胞生长的最佳营养环境,通过化学计量关系和灌注培养策略满足细胞生长所需的营养物质量,从而解决了营养物耗竭和副产物积累之间的矛盾。采用本发明所形成的工艺可将各种营养物控制在一个较低的合适浓度,既可保证细胞的营养供应,不会限制细胞的生长,又可降低有毒废物的产生,从而可获得高的细胞密度和产物浓度。The serum-free medium for animal cell culture is composed of more than 30 nutrients such as glucose, glutamine, various amino acids, various growth factors, regulatory and transport proteins in addition to inorganic salts. The lack of any nutrient will cause Cell growth is limited or even leads to cell death; and excessive nutrient abundance can cause a large accumulation of metabolic by-products such as ammonia and lactic acid, which can also cause cells to stop growing or die. Studies have shown that to effectively reduce the production of ammonia and lactic acid, it is necessary to reduce the concentration of glucose and glutamine. The present invention studies the metabolic law between cell growth, nutrient consumption and metabolic by-product accumulation by studying the kinetic characteristics of cell growth, nutrient consumption and metabolic by-product accumulation, and determines and controls the optimal nutritional environment for cell growth. The contradiction between nutrient depletion and by-product accumulation is resolved by meeting the amount of nutrients required for cell growth through stoichiometric relationships and perfusion culture strategies. The process formed by the present invention can control various nutrients at a lower suitable concentration, which can ensure the nutrient supply of cells without limiting the growth of cells, and can reduce the generation of toxic waste, thereby obtaining high Cell density and product concentration.
附图说明Description of drawings
图1为杂交瘤细胞连续灌注培养细胞生长与产物表达;Fig. 1 is hybridoma cell continuous perfusion culture cell growth and product expression;
图2为CHO细胞连续灌注培养细胞生长与产物表达;Figure 2 is CHO cell continuous perfusion culture cell growth and product expression;
具体实施方式Detailed ways
实施例1Example 1
将HB58杂交瘤细胞(从ATCC获得)在无血清培养基中采用???文献公开的方法进行传代适应后,在50升生物反应器中接种,接种密度2.0×105cells/ml。Are HB58 hybridoma cells (obtained from ATCC) employed in serum-free medium? ? ? After subculture adaptation according to the method disclosed in the literature, inoculate in a 50-liter bioreactor with an inoculation density of 2.0×10 5 cells/ml.
(2)在37℃、pH为7.2的条件下在无血清初始培养基中,培养60小时后,将无血清灌注培养基以1.0v/v day-1的灌注速率灌注进入生物反应器进行灌注培养,培养时间为60天,从第10天起开始收液,细胞密度可达2.40×107cells/ml,产物浓度可达624mg/ml;培养过程的细胞变化见图1,图中,曲线1为活细胞密度,曲线2为单抗浓度。(2) After culturing for 60 hours in serum-free initial medium at 37°C and pH 7.2, perfuse the serum-free perfusion medium into the bioreactor at a perfusion rate of 1.0v/v day -1 for perfusion Culture, the culture time is 60 days, and the liquid is collected from the 10th day, the cell density can reach 2.40×10 7 cells/ml, and the product concentration can reach 624mg/ml; the cell changes during the culture process are shown in Figure 1, in the figure, the curve 1 is the living cell density, curve 2 is the monoclonal antibody concentration.
通过本发明对培养过程的优化,细胞对于葡萄糖、谷氨酰胺以及其它各种氨基酸等营养物的利用率得到了极大的提高,乳酸、氨、丙氨酸等代谢副产物的生成速率大幅下降,细胞密度和产物浓度都获得了显著提高。与批培养的结果相比,反应器中细胞密度是批培养的11.32倍,产物浓度为9.18倍,过程产率为38.24倍(见表1)。
实施例2Example 2
将重组CHO细胞(rCHO SS3 A2,表达人抗凝血因子III)在B.BRAUN 2升生物反应器中接种,接种密度2.75×105cells/ml。Recombinant CHO cells (rCHO SS3 A2, expressing human anticoagulant factor III) were seeded in a 2-liter bioreactor of B.BRAUN at a seeding density of 2.75×10 5 cells/ml.
(2)在37℃、pH为7.2的条件下在无血清初始培养基中,培养40小时后,将无血清灌注培养基以0.58v/v day-1的灌注速率灌注进入生物反应器进行灌注培养,培养时间为28天,从第8天起开始收液,最高细胞密度可达1.1×107cells/ml,产物浓度可达390U/ml;培养过程的细胞变化见图2,图中,曲线3为活细胞密度,曲线4为总细胞密度,曲线5为产物(ATIII)表达量。(2) After culturing for 40 hours in serum-free initial medium at 37°C and pH 7.2, the serum-free perfusion medium was perfused into the bioreactor at a perfusion rate of 0.58v/v day -1 for perfusion Culture, the culture time is 28 days, and the liquid is collected from the 8th day, the highest cell density can reach 1.1×10 7 cells/ml, and the product concentration can reach 390U/ml; the cell changes during the culture process are shown in Figure 2, in the figure,
通过本发明对培养基和培养过程的优化,培养基中各种营养物被控制在较低的合适水平,使代谢副产物的生成速率大幅下降,因此细胞密度和产物浓度都获得了显著提高。与普通培养基批培养的结果相比,细胞密度和产物浓度分别提高6倍和5倍。Through the optimization of the culture medium and the culture process of the present invention, various nutrients in the culture medium are controlled at lower appropriate levels, so that the generation rate of metabolic by-products is greatly reduced, so the cell density and product concentration are significantly increased. Compared with the results of ordinary medium batch culture, the cell density and product concentration were increased by 6 times and 5 times, respectively.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100301993A CN1778903A (en) | 2005-09-29 | 2005-09-29 | A high-density continuous perfusion culture method for animal cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100301993A CN1778903A (en) | 2005-09-29 | 2005-09-29 | A high-density continuous perfusion culture method for animal cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1778903A true CN1778903A (en) | 2006-05-31 |
Family
ID=36769358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005100301993A Pending CN1778903A (en) | 2005-09-29 | 2005-09-29 | A high-density continuous perfusion culture method for animal cells |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1778903A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102191275A (en) * | 2010-02-09 | 2011-09-21 | 普莱克斯技术有限公司 | Method to enhance cell viability and biologic product yield |
| CN102389342A (en) * | 2011-07-06 | 2012-03-28 | 中国人民解放军第四军医大学 | In-vitro construction method of activated artificial bone and auxiliary circular perfusion inoculation loop |
| CN101988047B (en) * | 2010-05-13 | 2013-07-03 | 维亚生物科技(上海)有限公司 | Insect cell serum-free medium with low cost |
| CN103468638A (en) * | 2013-09-23 | 2013-12-25 | 天津瑞普生物技术股份有限公司 | Large-scale suspension cultivation method of 293 cells |
| CN103946366A (en) * | 2011-09-16 | 2014-07-23 | 安姆根有限公司 | Pre-programmed non-feedback controlled continuous feeding of cell cultures |
| CN105567627A (en) * | 2007-04-26 | 2016-05-11 | 中外制药株式会社 | Cell culture method using amino acid-enriched medium |
| CN107922919A (en) * | 2015-05-29 | 2018-04-17 | 勃林格殷格翰国际公司 | The perfusion of cell control in continuous culture |
| CN111793595A (en) * | 2020-07-23 | 2020-10-20 | 上海奥浦迈生物科技有限公司 | Serum-free culture medium for HEK293 cells |
| CN114729306A (en) * | 2019-09-27 | 2022-07-08 | 勃林格殷格翰国际公司 | Concentrated perfusion medium |
| CN116790483A (en) * | 2023-08-22 | 2023-09-22 | 苏州依科赛生物科技股份有限公司 | CHO cell serum-free medium and application thereof |
| US11958894B2 (en) | 2019-12-06 | 2024-04-16 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
-
2005
- 2005-09-29 CN CNA2005100301993A patent/CN1778903A/en active Pending
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105567627B (en) * | 2007-04-26 | 2020-09-29 | 中外制药株式会社 | Cell culture method using medium containing high concentration of amino acid |
| CN105567627A (en) * | 2007-04-26 | 2016-05-11 | 中外制药株式会社 | Cell culture method using amino acid-enriched medium |
| CN102191275A (en) * | 2010-02-09 | 2011-09-21 | 普莱克斯技术有限公司 | Method to enhance cell viability and biologic product yield |
| CN101988047B (en) * | 2010-05-13 | 2013-07-03 | 维亚生物科技(上海)有限公司 | Insect cell serum-free medium with low cost |
| CN102389342A (en) * | 2011-07-06 | 2012-03-28 | 中国人民解放军第四军医大学 | In-vitro construction method of activated artificial bone and auxiliary circular perfusion inoculation loop |
| US9803166B2 (en) | 2011-09-16 | 2017-10-31 | Amgen Inc. | Pre-programmed non-feedback controlled continuous feeding of cell cultures |
| CN103946366A (en) * | 2011-09-16 | 2014-07-23 | 安姆根有限公司 | Pre-programmed non-feedback controlled continuous feeding of cell cultures |
| CN103946366B (en) * | 2011-09-16 | 2017-08-11 | 安姆根有限公司 | The continuous feeding of the pre-programmed nonfeedback control of cell culture |
| CN103468638B (en) * | 2013-09-23 | 2016-01-20 | 天津瑞普生物技术股份有限公司 | A kind of extensive suspension culture method of 293 cells |
| CN103468638A (en) * | 2013-09-23 | 2013-12-25 | 天津瑞普生物技术股份有限公司 | Large-scale suspension cultivation method of 293 cells |
| CN107922919A (en) * | 2015-05-29 | 2018-04-17 | 勃林格殷格翰国际公司 | The perfusion of cell control in continuous culture |
| CN114729306A (en) * | 2019-09-27 | 2022-07-08 | 勃林格殷格翰国际公司 | Concentrated perfusion medium |
| US11958894B2 (en) | 2019-12-06 | 2024-04-16 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| US12012444B2 (en) | 2019-12-06 | 2024-06-18 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| US12012445B2 (en) | 2019-12-06 | 2024-06-18 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| US12049489B2 (en) | 2019-12-06 | 2024-07-30 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| US12054532B2 (en) | 2019-12-06 | 2024-08-06 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| US12054533B2 (en) | 2019-12-06 | 2024-08-06 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| US12077570B2 (en) | 2019-12-06 | 2024-09-03 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| CN111793595A (en) * | 2020-07-23 | 2020-10-20 | 上海奥浦迈生物科技有限公司 | Serum-free culture medium for HEK293 cells |
| CN116790483A (en) * | 2023-08-22 | 2023-09-22 | 苏州依科赛生物科技股份有限公司 | CHO cell serum-free medium and application thereof |
| CN116790483B (en) * | 2023-08-22 | 2023-10-20 | 苏州依科赛生物科技股份有限公司 | CHO cell serum-free medium and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2577972C2 (en) | Method of producing recombinant polypeptide | |
| CN109337861B (en) | CHO cell serum-free medium supporting high expression of product | |
| CN105331659B (en) | Improved cell culture medium | |
| CN101603026B (en) | Animal-source-free low-protein medium suitable for production of animal cell products | |
| JP6393267B2 (en) | Methods and systems for optimizing perfused cell culture systems | |
| CN1778903A (en) | A high-density continuous perfusion culture method for animal cells | |
| CN107964506B (en) | Fermentation feed supplement optimization control system and method | |
| CN101418330B (en) | Non protein culture medium adapted to large-scale culture of NSO cell and production of antibody | |
| JP2011521660A5 (en) | ||
| CN100362098C (en) | Serum-free medium suitable for large-scale culture of various animal cells | |
| CN101195817A (en) | Hybrid tumor cell amplification culture medium and uses thereof | |
| CN103224965A (en) | Method for producing pyrroloquinoline quinine through microbial fermentation and fermentation medium used in same | |
| Cheng et al. | Strategy for pH control and pH feedback-controlled substrate feeding for high-level production of L-tryptophan by Escherichia coli | |
| CN106399224B (en) | Serum-free and protein-free cell culture medium | |
| EP3328410B1 (en) | Method for increasing the glutathione level in cells | |
| CN113969257B (en) | Culture medium for producing insulin glargine | |
| US5156964A (en) | Methods for adapting cells for increased product production through exposure to ammonia | |
| CN1362514A (en) | Serumless medium suitable for growth and maintenance of young hamster kidney cell | |
| CN120924480B (en) | Cell culture medium, application thereof, cell culture method and kit | |
| CN102229908B (en) | Nutriment additive for high-density culture and product expression of animal cells | |
| Han et al. | Cultivation of Dictyostelium discoideum on an improved synthetic medium in a conventional bioreactor | |
| CN116515737B (en) | HEK293 cell and CHO cell universal culture medium and application thereof | |
| CN112481189B (en) | Method for domesticating schizochytrium limacinum and application thereof | |
| WO2013067850A1 (en) | Chemically defined culture medium for fermentation to produce succinic acid and application thereof | |
| CN1772883A (en) | Animal cell fed-batch culture method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |